The global real-time pcr and digital pcr market size is anticipated to reach USD 4.33 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 8.5% during the forecast period. Growing demand for Rapid Diagnostics Tests (RTDs) is one of the high impact rendering drivers for this market. The demand for RDTs is likely to witness strong growth as local governments across the globe seek to incorporate these tests to improve the diagnosis and treatment of infectious diseases.
The
emergence of RDTs as an important tool in the management of infectious diseases
owing to the ability to provide rapid results in remote areas with limited
healthcare infrastructure is likely to fuel the growth of the Polymerase Chain
Reaction (PCR) systems which are used extensively to conduct these diagnostic
procedures.
In
addition, high prevalence of infectious diseases is one of the major factors
contributing to the market growth. According to the estimates by the World
Health Organization (WHO), lower respiratory infections, diarrheal diseases,
and tuberculosis were ranked among the top ten causes of deaths worldwide in 2016.
New cases of other infectious diseases, such as HIV/AIDS and malaria among
others continue to witness sharp increase in developing countries which is
expected to substantially increase the patient population, driving the need for
better diagnosis options.
Furthermore,
inorganic growth strategies such as mergers and acquisitions employed by major
PCR manufacturers to broaden their product portfolio and to develop novel qPCR
and dPCR products is another factor expected to propel the market during the
forecast period. For instance, in January 2017, RainDance Technologies, Inc.
was acquired by Bio-Rad Laboratories, Inc. which is expected to strengthen the
company’s position in the field of droplet digital PCR and next generation
sequencing.
Full Research Report On Real-time PCR & Digital PCR Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/real-time-pcr-qpcr-digital-pcr-dpcr-market
Real-time PCR
(qPCR) & Digital PCR (dPCR) Market Report Highlights
- qPCR held the
largest market share in 2018 due to the accuracy and wide applications of
the technology in quantification of gene expression, pathogen detection
and microRNA analysis
- Digital PCR
is estimated to be the fastest growing segment due to precise quantification
of target sequences
- Consumables
and reagents led the product segment and is likely register the fastest
CAGR of 8.9% over the forecast period due strong uptake in the use of PCR
kits in diagnostic tests
- Research
application was the largest segment in terms of value in 2018, due to
wide-spread use in research areas, such as stem cells, microbiology, and
agriculture
- Clinical
application is expected to witness robust growth over the forecast period
due to the adoption of automated processes
- North America
held the largest market share in terms of revenue in 2018 due launch of
new PCR products along with rising demand for rapid diagnostic tests
- Asia Pacific
is projected to register comparatively strong growth during the forecast
period owing to burgeoning patient population as a result of prevalence of
infectious diseases
- Prominent
players in the qPCR and dPCR market include Bio-Rad Laboratories; Thermo
Fisher Scientific Inc.; Qiagen N.V.; Abbott Laboratories, Inc.; and others
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/real-time-pcr-qpcr-digital-pcr-dpcr-market/request/rs1
Real-time PCR
(qPCR) & Digital PCR (dPCR) Market Segmentation
Grand View Research has
segmented the global qPCR and dPCR market on the basis of technology, product,
application, and region:
Real-time PCR
(qPCR) & Digital PCR (dPCR) Technology Outlook (Revenue, USD Million, 2014
- 2026)
- Quantitative
- Digital
Real-time PCR
(qPCR) & Digital PCR (dPCR) Product Outlook (Revenue, USD Million, 2014 -
2026)
- Consumables & Reagents
- Instruments
- Software & Services
Real-time PCR
(qPCR) & Digital PCR (dPCR) Application Outlook (Revenue, USD Million, 2014
- 2026)
- Clinical
- Pathogen Testing
- Blood Screening
- Oncology Testing
- Others
- Research
- Forensic and Others
Real-time PCR
(qPCR) & Digital PCR (dPCR) Regional Outlook (Revenue, USD Million, 2014 -
2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Singapore
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment